These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 15141981)

  • 1. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
    Kuca K; Cabal J
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro reactivation of acetylcholinesterase inhibited by cyclosarin using bisquaternary pyridinium aldoximes K005, K033, K027 AND K048.
    Kuca K; Sevelová-Bartosová L; Krejcová-Kunesová G
    Acta Medica (Hradec Kralove); 2004; 47(2):107-9. PubMed ID: 15446359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisquaternary oximes as reactivators of tabun-inhibited human brain cholinesterases: an in vitro study.
    Kuca K; Jun D; Cabal J; Musilova L
    Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):25-8. PubMed ID: 17577312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J
    Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
    Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New quaternary pyridine aldoximes as casual antidotes against nerve agents intoxications.
    Kuca K; Bartosová L; Jun D; Patocka J; Cabal J; Kassa J; Kunesová G
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):75-82. PubMed ID: 16170392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques.
    Bajgar J; Hajek P; Zdarova JK; Kassa J; Paseka A; Slizova D; Krs O; Kuca K; Jun D; Fusek J; Capek L
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):790-7. PubMed ID: 21054236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
    Musilek K; Holas O; Kuca K; Jun D; Dohnal V; Opletalova V; Dolezal M
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3172-6. PubMed ID: 17383875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective bisquaternary reactivators of tabun-inhibited AChE.
    Kuca K; Cabal J; Musilek K; Jun D; Bajgar J
    J Appl Toxicol; 2005; 25(6):491-5. PubMed ID: 16092078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of human brain homogenate cholinesterases inhibited by Tabun using newly developed oximes K117 and K127.
    Kuca K; Cabal J; Jung YS; Musilek K; Soukup O; Jun D; Pohanka M; Musilova L; Karasová J; Novotný L; Hrabinova M
    Basic Clin Pharmacol Toxicol; 2009 Sep; 105(3):207-10. PubMed ID: 19473310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the ability of a new bispyridinium oxime--1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
    Kuca K; Kassa J
    J Enzyme Inhib Med Chem; 2003 Dec; 18(6):529-35. PubMed ID: 15008517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of the efficacy of the reactivators of acetylcholinesterase inhibited with tabun].
    Cabal J; Kuca K; Jun D; Bajgar J; Hrabinová M
    Ceska Slov Farm; 2005 Jul; 54(4):192-5. PubMed ID: 16124202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the potency of newly developed oximes (K005, K027, K033, K048) and currently used oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited rat brain acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J
    J Toxicol Environ Health A; 2005 Apr; 68(8):677-86. PubMed ID: 15901095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro reactivation of acetylcholinesterase using the oxime K027.
    Kuca K; Kassa J
    Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterases.
    Kuca K; Cabal J; Jun D; Musilek K
    Neurotox Res; 2007 Feb; 11(2):101-6. PubMed ID: 17449453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Kunesova G
    J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
    Kassa J; Kuca K; Cabal J; Paar M
    J Toxicol Environ Health A; 2006 Oct; 69(20):1875-82. PubMed ID: 16952906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
    Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.